| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044475261 |
| P356 | DOI | 10.1007/S11926-996-0069-4 |
| P698 | PubMed publication ID | 11123040 |
| P2093 | author name string | P Boulos | |
| J D Adachi | |||
| G Ioannidis | |||
| P2860 | cites work | The ineffectiveness of cyclical oral clodronate on bone mineral density in glucocorticoid-treated patients with giant-cell arteritis | Q32169619 |
| Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids | Q33557023 | ||
| Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis--a population based study | Q33566022 | ||
| Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group | Q34409983 | ||
| Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients | Q34743427 | ||
| A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment | Q35532455 | ||
| Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis? | Q35547316 | ||
| Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial | Q37385973 | ||
| Effects of corticosteroids on bone turnover | Q40909499 | ||
| Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis | Q41150682 | ||
| Corticosteroid-induced bone loss in men. | Q41722965 | ||
| Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial | Q45102005 | ||
| Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis | Q47915659 | ||
| Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group | Q48527134 | ||
| Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis | Q49174113 | ||
| Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy | Q51647891 | ||
| Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group | Q57224307 | ||
| Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial | Q57224477 | ||
| Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis | Q57224532 | ||
| Intermittent Etidronate and Corticosteroid-Induced Osteoporosis | Q60199017 | ||
| Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis | Q67283849 | ||
| Intermittent cyclical etidronate treatment of postmenopausal osteoporosis | Q67300571 | ||
| Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells | Q68485907 | ||
| Bone loss in response to long-term glucocorticoid therapy | Q68714839 | ||
| Corticosteroid effects on proximal femur bone loss | Q70242614 | ||
| Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study | Q70610010 | ||
| Testosterone therapy in glucocorticoid-treated men | Q71098016 | ||
| Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis | Q71596137 | ||
| Steroid-induced fractures and bone loss in patients with asthma | Q71773998 | ||
| Glucocorticoid-induced osteoporosis | Q71774006 | ||
| Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis | Q71843572 | ||
| Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin | Q72081327 | ||
| Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study | Q72236408 | ||
| Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss | Q72359405 | ||
| Mechanisms of rapid bone loss following cardiac transplantation | Q72386274 | ||
| Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids | Q72523802 | ||
| Generalised bone loss in patients with early rheumatoid arthritis | Q72682386 | ||
| Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids | Q72767544 | ||
| Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study | Q73130933 | ||
| Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women | Q73911971 | ||
| Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis | Q74595147 | ||
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group | Q74817608 | ||
| Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis | Q77875664 | ||
| P433 | issue | 1 | |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 53-61 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Glucocorticoid-induced osteoporosis | |
| P478 | volume | 2 |
| Q37200430 | Glucocorticoids and osteocyte autophagy |
| Q50559340 | Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. |
| Q28576330 | Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats |
Search more.